Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Javier Mallada-Frechín"'
Autor:
Andrea Torregrosa García, Vicente Medrano‐Martínez, Adel Abuomar, Irene Francés‐Pont, Lidia Hernández‐Rubio, Sebastian Fernández‐Izquierdo, Javier Mallada‐Frechin
Publikováno v:
Clinical Case Reports, Vol 8, Iss 8, Pp 1346-1348 (2020)
Abstract Migraine‐like associated with chest pain is an alarming association and forces us to rule out the presence of a secondary cause. That must be taken into account in the differential diagnosis of craniofacial hemicranial pain that appears in
Externí odkaz:
https://doaj.org/article/7c2bd8f847f24ef4bf389ff4332bc6a2
Autor:
Sara Gil-Perotin, Jéssica Castillo-Villalba, Joan Carreres-Polo, Arantxa Navarré-Gimeno, Javier Mallada-Frechín, Francisco Pérez-Miralles, Francisco Gascón, Carmen Alcalá-Vicente, Laura Cubas-Nuñez, Bonaventura Casanova-Estruch
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
The clinical diagnosis of patients with autoantibodies directed to conformational myelin oligodendrocyte glycoprotein MOG-IgG, can be challenging because of atypical clinical presentation. MOG-IgG seropositivity has been reported in several demyelina
Externí odkaz:
https://doaj.org/article/c6afc20e866a484690af1e431b81a5ff
Autor:
Ramón Villaverde-González, Javier Mallada Frechín, Antonio Candeliere-Merlicco, Angel P. Sempere, Eladio Aparicio Castro, María Aránzazu Alonso-Frías, Andrés Carrillo Alcaraz
Publikováno v:
Multiple Sclerosis and Related Disorders. 46:102518
Background For safety reasons multiple sclerosis (MS) treatment guidelines recommend stopping or delaying the onset of disease-modifying therapies (DMT) before a planned pregnancy, but disease stability after DMT discontinuation is not well studied.
Autor:
Javier Mallada Frechín
Publikováno v:
Neurodegenerative disease management. 8(3)
Aim: To examine evolution in activities of daily living (ADL) in patients with multiple sclerosis spasticity during long-term use of tetrahydrocannabinol (THC):cannabidiol (CBD) oromucosal spray. Methods: Functional impairment was assessed retrospect
Autor:
Francisco Barrero, Javier Mallada-Frechin, María Luisa Martínez-Ginés, María Eugenia Marzo, Virginia Meca-Lallana, Guillermo Izquierdo, José Ramón Ara, Celia Oreja-Guevara, José Meca-Lallana, Lucía Forero, Irene Sánchez-Vera, María José Moreno, in representation of the MS NEXT study investigators
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230846 (2020)
PurposeThe objective of this study was to characterize the demographic and clinical profile of RRMS patients receiving fingolimod in Spain, and to evaluate drug effectiveness and safety in clinical practice.MethodsThis observational, retrospective, m
Externí odkaz:
https://doaj.org/article/35e01650c3644a1095a86b39b5d34dd7